Browse Items (30 total)

• Threading the NEIDL (National Emerging Infectious Diseases Laboratories)

  Tags Basic Science Research, Biosafety, Ebola, Lab, Laboratory, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: American Society for Microbiology
  Subject: Research
  Item Type: Video
  Date Last Updated: 2018-01-02
  Description: This video explores the National Emerging Infectious Diseases Laboratories (NEIDL) security, a Biological Safety Level (BSL)-4 safety suit, and the facility.

• Chimpanzee adenovirus type 3 vectored Ebola vaccine: expanding the field

  Tags Ebola, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: Bavari, Sina, and Patrick L. Iversen.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2020-03-19
  Description: Two phase 2 randomised clinical trials evaluating ChAd3-EBO-Z administered to healthy adults in Cameroon, Mali, Nigeria, and Senegal and healthy children in Mali and Senegal are reported by Milagritos Tapia and colleagues in The Lancet Infectious…
• 

  Ebola virus disease and pregnancy - A review of the current knowledge of Ebola virus pathogenesis, maternal and neonatal outcomes

  Tags Labor and Delivery, Outcomes, R-Res&Pub, R-SP, Vaccine Study
  Creator: Bebell, Lisa M., Titilope Oduyebo, and Laura E. Riley.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2017-03-15
  Description: The 2014-2016 Ebola virus disease (EVD) outbreak in West Africa devastated local health systems and caused thousands of deaths.

• Vaccine development during global epidemics: the Zika experience

  Tags Epidemic, Outbreaks, Pandemic, R-Lab, R-Res&Pub, Vaccine Study
  Creator: Castanha, Priscila M. S., and Ernesto T. A. Marques.
  Subject: Laboratory
  Item Type: Publication
  Date Last Updated: 2020-05-06
  Description: The North and South American continents experienced a major epidemic of Zika virus in 2015–16, which infected up to 70% of the population in some areas.

• Ebola Recommendations for Organizations

  Tags Clinical Trial, Ebola, Outbreaks, Personal Protective Equipment (PPE), R-PM, R-PPE, Travel Screening, Vaccine Study
  Creator: CDC
  Subject: Personnel Management
  Item Type: Guide
  Date Last Updated: 2019-04-16
  Description: Recommendations for organizations sending US-based health care or emergency response workers to areas with Ebola outbreaks and predeparture assessment of any workers traveling from Ebola outbreak areas to the United States.
• 

  Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020

  Tags CDC, Ebola, Guidance Document, Immunology, R-Res&Pub, R-T&C, Vaccine Study, Viral Hemorrhagic Fever
  Creator: CDC
  Subject: Treatment & Care
  Item Type: Publication
  Date Last Updated: 2021-01-08
  Description: This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant human serum albumin and…
• 

  Smallpox/Monkeypox Vaccine (JYNNEOS™): What You Need to Know

  Tags Mpox, R-T&C, Smallpox, Treatment and Care, Vaccine Study
  Creator: CDC
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2022-08-23
  Description: VACCINE INFORMATION STATEMENT

• Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection

  Tags Ebola, Immunology, Outbreaks, R-Res&Pub, Research, Vaccine Study
  Creator: Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albariño CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, Goff AJ, Spiropoulou CF, Saphire EO, Cavet G, Kawaoka Y, Mehta AK, Glass PJ, Boyd SD,…
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2019-05-30
  Description: Ebola virus (EBOV) remains a public health threat. We performed a longitudinal study of B cell responses to EBOV in four survivors of the 2014 West African outbreak.

• Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination.

  Tags Antibodies, Ebola, Immunology, R-Res&Pub, Vaccine Study, Virology
  Creator: Ellebedy, A. H., K. J. Jackson, H. T. Kissick, H. I. Nakaya, C. W. Davis, K. M. Roskin, A. K. McElroy, C. M. Oshansky, R. Elbein, S. Thomas, G. M. Lyon, C. F. Spiropoulou, A. K. Mehta, P. G. Thomas, S. D. Boyd, and R. Ahmed
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2016-10
  Description: Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination.

• Ebola therapies: an unconventionally calculated risk.

  Tags Clinical Trial, Ebola, Outbreaks, R-Res&Pub, Therapeutics, Vaccine Study
  Creator: Fallah MP, Skrip LA.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2019-01-24
  Description: This article reviews the testing of Ebola therapies during the outbreak.